表紙
市場調査レポート

インドの医薬品原薬(API)市場

Active Pharmaceutical Ingredients (API) Market in India 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 323009
出版日 ページ情報 英文 64 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
インドの医薬品原薬(API)市場 Active Pharmaceutical Ingredients (API) Market in India 2015-2019
出版日: 2015年01月14日 ページ情報: 英文 64 Pages
概要

医薬品原薬(API)は、医薬品の製造に使用される薬理効果を有する活性物質です。インドにおけるAPI市場は、2014年から2019年の間、10.76%の複合年間成長率(CAGR)で拡大することが予測されています。

当レポートでは、インドにおける医薬品原薬(API)市場の現況と今後の成長見通しを調査しており、製造工程別および治療領域別の市場規模とその予測、市場の成長因子と課題、主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要

第7章 インドのAPI市場

  • 市場規模と予測
  • 輸出と国内消費
  • ファイブフォース分析

第8章 製造工程タイプ別の市場区分

第9章 治療領域別の市場区分

  • 抗感染症
  • 心血管および造血系
  • 中枢神経系
  • 胃腸および肝胆道系
  • 呼吸器系
  • 腫瘍

第10章 購入基準

第11章 市場成長因子

第12章 成長因子とその影響

第13章 市場の課題

第14章 成長因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
  • Key ベンダーランキング
  • その他の有力ベンダー

第18章 主要ベンダーの分析

  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy's Laboratories

第19章 関連レポート

目次
Product Code: IRTNTR5188

About Active Pharmaceutical Ingredients

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.

In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors

  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy's Laboratories

Other Prominent Vendors

  • Anuh Pharma
  • Alembic Pharmaceuticals
  • A. R. Life Sciences
  • Atul Bioscience
  • Biocon
  • Cadila Pharmaceuticals
  • Calyx Chemicals & Pharmaceuticals
  • CIRON Drugs and Pharmaceuticals
  • CTX Life Sciences
  • Dishman Pharmaceuticals & Chemicals
  • Elder Pharmaceuticals
  • Emcure Pharmaceuticals
  • FDC
  • Glenmark Pharmaceuticals
  • Hetero Drugs
  • Hikal
  • Ind-Swift Laboratories
  • Ipca Laboratories
  • J. B. Chemicals and Pharmaceuticals
  • Laurus Labs
  • Lupin
  • Mangalam Drugs & Organics
  • Mylan Laboratories
  • Orchid Chemicals and Pharmaceuticals
  • Ranbaxy Laboratories
  • Sandoz
  • Sequent Scientific
  • Shasun Pharmaceuticals
  • Sterling Biotech
  • Sun Pharmaceutical Industries
  • The Piramal Group
  • Torrent Pharmaceuticals
  • Unichem Laboratories
  • Wockhardt

Market Driver

  • Strong Preference for Generic Drugs
  • For a full, detailed list, view our report

Market Challenge

  • Regulatory Ban
  • For a full, detailed list, view our report

Market Trend

  • Emergence of Africa
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

07. API Market in India

  • 07.1. Market Size and Forecast
  • 07.2. Export and Domestic Consumption
  • 07.3. Five Forces Analysis

08. Market Segmentation by Type of Production Process

09. Market Segmentation by Area of Therapy

  • 09.1. API Market in India for Anti-infectives
    • 09.1.1. Market Segmentation by Type
  • 09.2. API Market in India for the Cardiovascular and Hematopoietic System
    • 09.2.1. Market Segmentation by Type
  • 09.3. API Market in India for the Central Nervous System
    • 09.3.1. Market Segmentation by Type
  • 09.4. API Market in India for the Gastro-intestinal and Hepatobiliary System
    • 09.4.1. Market Segmentation by Type
  • 09.5. API Market in India for the Respiratory System
    • 09.5.1. Market Segmentation by Type
  • 09.6. API Market in India for Oncology
    • 09.6.1. Market Segmentation by Type

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
  • 17.2. Key Vendor Ranking 2014
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Aurobindo Pharma
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Geographical Segmentation by Revenue 2014
    • 18.1.5. Business Strategy
    • 18.1.6. Recent Developments
    • 18.1.7. SWOT Analysis
  • 18.2. Cipla
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Product Segmentation
    • 18.2.4. Geographical Segmentation by Revenue 2014
    • 18.2.5. Business Strategy
    • 18.2.6. Recent Developments
    • 18.2.7. SWOT Analysis
  • 18.3. Dr. Reddy's Laboratories
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2014
    • 18.3.4. Business Segmentation by Revenue 2013 and 2014
    • 18.3.5. Geographical Segmentation by Revenue 2014
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: API Market in India: Segmentation
  • Exhibit 3: API Market in India: Segmentation by Type of Production Process
  • Exhibit 4: API Market in India: Segmentation by Area of Therapy
  • Exhibit 6: API Market in India 2014-2019 (US$ billion)
  • Exhibit 7: API Market in India: Export and Domestic Consumption 2014
  • Exhibit 8: API Market in India: Market Segmentation by Type of Production Process 2014
  • Exhibit 9: API Market in India: Segmentation by Area of Therapy 2014
  • Exhibit 10: API Market in India for Anti-infectives: Segmentation by Type 2014
  • Exhibit 11: API Market in India for the Cardiovascular and Hematopoietic System: Segmentation by Type 2014
  • Exhibit 12: API Market in India for the Central Nervous System: Segmentation by Type 2014
  • Exhibit 13: API Market in India for the Gastro-intestinal and Hepatobiliary System: Segmentation by Type 2014
  • Exhibit 14: API Market in India for the Respiratory System: Segmentation by Type 2014
  • Exhibit 15: API Market in India for Oncology: Segmentation by Type 2014
  • Exhibit 16: Small Molecule Drugs: Patent Expiries 2013-2016
  • Exhibit 17: WHO's List of Prequalified API for Vendors in India (22nd October, 2014)
  • Exhibit 18: Biologic Drugs: Patent Expiries 2014-2019 (EU and US)
  • Exhibit 19: API Market in India: Segmentation by Type of Vendors 2014
  • Exhibit 20: Aurobindo Pharma: Business Segmentation
  • Exhibit 21: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
  • Exhibit 22: Cipla: Product Segmentation
  • Exhibit 23: Cipla: Geographical Segmentation by Revenue 2014
  • Exhibit 24: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2014
  • Exhibit 25: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
  • Exhibit 26: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
Back to Top